Search

Sort & Filters

Filters

Content type
Related News Topic
Year

36 results for "Musculoskeletal Diseases Program"

36 results for "Musculoskeletal Diseases Program"

GlaxoSmithKline and HSCI form collaborative alliance

Page
This summer GlaxoSmithKline (GSK) and HSCI entered into a five-year, $25 million-plus collaborative agreement to build a unique alliance in stem cell science to hasten the development of treatments and cures for a range of diseases. GSK’s investment, one...

HSCI Matching Challenge Update

News
The Harvard Stem Cell Institute (HSCI) is pleased to announce the success of the 2015–16 General Fund Matching Challenge. Throughout fiscal year 2016, HSCI saw an outpouring of unrestricted funding, resulting in $2.6 million in new gifts and pledges. This...

Seed Grant Awards

Page
Fall 2021 Collaborative Seed Grant Recipients Project Lead Collaborating PI Affiliation Title Research Area Yingzi Yang, PhD Jennifer Gibbs, DDS, PhD Harvard School of Dental Medicine Sensory nerve regulation of dentin repair in molars Dental diseases...

Yingzi Yang, Ph.D.

Person

Yingzi Yang's research has bridged discoveries of fundamental mechanisms with the characterization and treatment of diseases including severe birth defects, osteoporosis, osteoarthritis and heterotopic bone formation.

The Yang lab uses molecular...

The first stem cell models of human spine development

News
HSCI researchers set the stage for better understanding musculoskeletal disorders and advancing treatments More than 20 years ago, the lab of developmental biologist Olivier Pourquié discovered a sort of cellular clock in chicken embryos where each “tick”...

Gene-Editing: Therapeutic Strategies for Muscle Disease

Events
Guest speaker: Amy Wagers, PhD Program of the Harvard Alumni Association. Registration and $5.00 fee is required of all, though Harvard students are admitted free of charge. A leader in the field of stem cell biology, Dr. Amy Wagers has done...

Company Startups

Page
A key part of HSCI's mission is to help move discoveries out of the lab and into the market. One strategy is for our faculty to form startup companies based on their work. The following companies have been founded or co-founded by HSCI scientists: CRISPR...

Jenna Galloway, Ph.D.

Person

The Galloway lab aims to apply new discoveries to developing regenerative biology solutions that can better heal and repair tendon and ligament injuries.

Injuries to tendons and ligaments result in a slow, imperfect regenerative response. In most cases...

David M. Langenau, PhD

Person

The Langenau lab investigates how it is that tumors can be remade following conventional chemotherapeutic intervention, using zebrafish as a model.

Our research focuses on using the zebrafish to better understand human cancer and to develop novel...

Cell-based Therapies & Tissue Engineering Short Course 2016

Events
The Skeletal Research Center and the Department of Biology of Case Western Reserve University are pleased to present the fifteenth annual short course entitled: "Cell-Based Therapies and Tissue Engineering", running from May 24 through May 26, 2016, in...